Coya Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Coya Therapeutics has a total shareholder equity of $32.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $37.4M and $5.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$35.99m |
| Equity | US$32.39m |
| Total liabilities | US$5.00m |
| Total assets | US$37.39m |
Recent financial health updates
Coya Therapeutics (NASDAQ:COYA) Is In A Good Position To Deliver On Growth Plans
Mar 26
We Think Coya Therapeutics (NASDAQ:COYA) Needs To Drive Business Growth Carefully
Sep 06Here's Why We're Watching Coya Therapeutics' (NASDAQ:COYA) Cash Burn Situation
May 17Recent updates
Coya Therapeutics (NASDAQ:COYA) Is In A Good Position To Deliver On Growth Plans
Mar 26Coya Therapeutics In Catbird Seat Following Dr. Reddy's Licensing Deal
Feb 13Coya Therapeutics: Interesting Early Data In CNS Diseases, Very Low Cash Position
Jan 13We Think Coya Therapeutics (NASDAQ:COYA) Needs To Drive Business Growth Carefully
Sep 06Here's Why We're Watching Coya Therapeutics' (NASDAQ:COYA) Cash Burn Situation
May 17Financial Position Analysis
Short Term Liabilities: COYA's short term assets ($37.3M) exceed its short term liabilities ($4.3M).
Long Term Liabilities: COYA's short term assets ($37.3M) exceed its long term liabilities ($681.3K).
Debt to Equity History and Analysis
Debt Level: COYA is debt free.
Reducing Debt: COYA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: COYA has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: COYA has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 41.3% each year